SI Shoulder Innovations, Inc.
USHealthcareAs of 2026-08-24
Why SI matters now
Shoulder Innovations, Inc. (SI) is a US stock in Healthcare. The latest InvestLog snapshot shows $22.26 with +0.91% on the session and $461.6M in market capitalization; recent performance reads 1-month +24.25% and YTD +29.72%.
The latest financial table shown here is Q1 2026, with revenue of $16.7M, net income of $-8.4M, and EPS of $-0.41. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -11.4%.
The latest indexable market news headline is "Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer" from PRNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $19.00; recent insider activity includes Ahearn Matthew Fraser filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
2.88
P/S
7.14
EV/EBITDA
-9.44
DCF Value
$-150.70
FCF Yield
-11.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.5%
Operating Margin
-57.5%
Net Margin
-81.8%
ROE
-35.3%
ROA
-27.5%
ROIC
-20.9%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $16.7M | $-8.4M | $-0.41 |
| Q4 2025 | $14.4M | $-7.8M | $-0.38 |
| FY 2025 | $47.3M | $-40.4M | $-1.96 |
| Q3 2025 | $11.8M | $-8.7M | $-0.43 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$19.00
Target (Median)
$19.00
Target Range
$19.00 - $19.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Specialties
Country
US
Exchange
—
Beta
-1.07
Shoulder Innovations, Inc. is a medical technology firm that engineers and produces sophisticated devices. The company is particularly recognized for designing an innovative shoulder replacement system. Co-founded in 2009 by Stephen B. Gunther and Michael DeVries, its main corporate office is situated in Grand Rapids, Michigan.